This Study Aims to Quantify Decisional Regret as Well as Quality of Life in Patients With Low- to High-risk Cancer and High Burden of Symptoms Undergoing Radiotherapy Using Established Questionnaires.

In this prospective registry study, patients with low-, intermediate- and high-risk tumor entities as well as patients with high symptom burden of any tumor entity in palliative constellation with indication for radiation treatment are included. This radiation treatment can be applied either as 3D-conformal RT or IGRT. The duration of treatment can range from one day to several weeks. For the primary endpoint as well as the secondary clinical and other exploratory endpoints, the 3 groups will be compared in terms of DR, QoL, toxicities and treatment plan parameters

NCT Number	NCT06921863
Lead Sponsor	University Medical Center Goettingen
Conditions	Quality of Life (QOL), Decision Making ,Shared
Enrollment	165 participants
Start Date	2025-07-01
Primary Completion	2029-10-01 (estimated)
Study Completion	2032-10-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-10